Abstract:Objective: This study aimed to evaluate the effects of salmon calcitonin, and calcium and vitamin D treatment on bone mineral density, serum and synovial fluid bone formation and resorption markers in patients with osteoporosis. Methods: The study was completed with twenty-five osteoporosis patients divided into two groups: The 15 patients comprising Group I (1 male and 14 females; mean age: 67.0±12.0) were administered calcitonin treatment in addition to calcium and vitamin D. The 10 patients in Group II (3 males and 7 females; mean age 68.0±16.0) were administered calcium and vitamin D only. Serum and synovial fluid calcium phosphorus, alkaline phosphatase, calcitonin, C-telopeptide (CTx), N-telopeptide (NTx) and sialoprotein levels, and bone densitometries were determined at the beginning and at the end of one year of treatment. Results: In the calcitonin and calcium and vitamin D treatment group (Group I), femoral neck density scores were decreased and vertebrae scores were increased after one-year treatment. Both scores were increased in the non-calcitonin group (Group II). In Group I, synovial fluid levels of calcitonin, sialoprotein and NTx were decreased, and synovial fluid CTx levels showed no change. The only decrease that was statistically significant was that in calcitonin levels. In Group II, synovial fluid calcitonin levels were decreased, synovial fluid CTx levels were increased and synovial fluid NTx and sialoprotein level were unchanged. These changes were not statistically significant. Serum changes in the parameters were not statistically significant in either group. Conclusion: In osteoporosis, salmon calcitonin treatment affects synovial fluid bone formation and absorption marker levels. Advanced studies are needed to evaluate the mechanisms by which this takes place, and to explain the relationship between osteoporosis and articular cartilage metabolism.

Stability of Salmon Calcitonin Nasal Spray Under Simulated Transportation and Usage Condition

[Study on Pulmonary Delivery System of Salmon Calcitonin in Rats].

Transdermal Delivery of Salmon Calcitonin Using a Dissolving Microneedle Array: Characterization, Stability, and In vivo Pharmacodynamics

Efficacy and safety of Miacalcic ( salmon calcitonin ) in osteoporotic fracture patients: A 12 weeks,open-label,multicenter,observational study

The Hypocalcemia Effect of Salmon Calcitonin Ultra-Flexible Liposomes after Intranasal Administration in Rats

Novel Nano-Spray-dried Powders for Efficient Pulmonary Drug Delivery.

Quality Assessment and Stability Test of Basic Fibroblast Growth Factor Nasal Spray

Thermosensitive Polysaccharide Hydrogel As a Versatile Platform for Prolonged Salmon Calcitonin Release and Calcium Regulation

Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery.

Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles

Thermosensitive Hydrogel Based on Poly(2-Ethyl-2-Oxazoline)–Poly(D,L-Lactide)–Poly(2-Ethyl-2-Oxazoline) for Sustained Salmon Calcitonin Delivery

Analysis the effect of salmon calcitonin combined with azole phosphonic acid in the treatment of osteoporosis in elderly men

Orally Delivered Salmon Calcitonin-Loaded Solid Lipid Nanoparticles Prepared by Micelle-Double Emulsion Method Via the Combined Use of Different Solid Lipids.

Stability of Ceylon Spinach (basella Alba L.) Seed Protein Extract and Its Effect on the Microbiological, Chemical and Sensory Quality of Sturgeon Fillets Stored at 4 °C

Research on the stability of finished salvianolate transfusion

Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients

Research on storage stability differences between ceftriaxone sodium products

Investigation on the compatible stability of sodium tanshinone ⅡA sulfonate injection with 10 different drugs

Preparation and Ciliotoxicity of Interferon Α-2B Nasal Spray

Safety of a preservative-free acidified saline nasal spray: a randomized, double-blind, placebo-controlled, crossover clinical trial

Effects of Tricaine Methanesulphonate (MS-222) on Physiological Stress and Fresh Quality of Sea Bass (Lateolabrax maculatus) under Simulated High-Density and Long-Distance Transport Stress